Castle Biosciences, Inc. - Common stock - Çeyreklik Bilanço (NASDAQ:CSTL) | MetaTrader

Tam grafiği aç Full chart

Haberler

BTIG, yüksek maliyetler nedeniyle Castle Biosciences hisse hedefini düşürdü

Castle Biosciences 1Ç 2026: Gelir beklentiyi aştı, rehberlik yükseltildi

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know